Comparison of transcatheter arterial chemoembolization with raltitrexed plus liposomal doxorubicin vs. tegafur plus pirarubicin for unresectable hepatocellular carcinoma

BACKGROUND: There is still no general consensus on the optimal chemotherapeutic agent selection for transcatheter arterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC). The present study aimed to compare the efficacy and safety of TACE with raltitrexed plus liposomal doxor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Autores principales: Liao, Rui, Zhang, Xing-Diao, Li, Gui-Zhong, Qin, Ke-Le, Yan, Xiong
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475337/
https://ncbi.nlm.nih.gov/pubmed/32953158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-59
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares